Optomed Plc Stock Exchange Release 25 February 2026 at 9.00, Helsinki
Optomed Annual Report 2025 published
Optomed's Annual Report 2025 has been published. The Annual Report includes the company's consolidated and parent company financial statements, the report of the board of directors, the auditor's report, corporate governance statement and remuneration report for governing bodies.
Optomed's Financial Statements are published in accordance with the European Single Electronic Format (ESEF) reporting requirements. KPMG Oy Ab, authorised public accountants, has provided an independent auditor's reasonable assurance report on Optomed's ESEF Financial Statements.
The Annual Report is attached to this release as a PDF file and it is available in English and Finnish on the corporate website www.optomed.com/investors/. The financial statements are attached as an XHTML file.
Optomed Plc
Further enquiries
Sakari Knuutti, CFO, Optomed Plc, sakari.knuutti@optomed.com
Optomed in Brief
Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld screening devices fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries.